Kaplan, Mark H.
Kaminski, Mark
Estes, Judith M.
Gitlin, Scott D.
Zahn, Joseph
Elder, James T.
Tejasvi, Trilokraj
Gensterblum, Elizabeth
Sawalha, Amr H.
McGowan, Joseph Patrick
Dosik, Michael H.
Direskeneli, Haner
Direskeneli, Guher Saruhan
Adebamowo, Sally N.
Adebamowo, Clement A.
Sajadi, Mohammad
Contreras-Galindo, Rafael
Funding for this research was provided by:
CPAR (05-5089)
National Institutes of Health (1R01AI110259-01A1, 1I01BX002358-01A1)
National Cancer Institute (K22CA177824)
Scleroderma Foundation
Article History
Received: 1 November 2018
Accepted: 15 April 2019
First Online: 2 May 2019
Ethics approval and consent to participate
: All patient samples were acquired with written informed consent and with the approval of the respective Institutional Review Boards. Review boards include the Institutional Review Board of the University of Michigan Medical School (IRBMED), The University of Maryland Institutional Review Board, The MACS Institutional Review board (CAMACS), The Veterans Affairs Central Institutional Review Board, and the Northshore University Health System Institutional Review Board.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.